A phase 2, randomized, double-blind, placebo-controlled study of senolytic molecule UBX0101 in the treatment of painful knee osteoarthritis. (April 2021) - Lane, N.; Hsu, B.; Visich, J.; Xie, B.; Khan, A.; Dananberg, J.